CLINICAL_TRIALS trial_result · 2019-05-21

Clinical Trial Update: A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) [Phase 2]

Phase 2 clinical trial evaluating ALKS 5461 for major depressive disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alkermes, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-05-21